Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04172844
Title Pevonedistat, Azacitidine, and Venetoclax for the Treatment of Patients With Acute Myelogenous Leukemia (PAVE)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Ehab L Atallah

acute myeloid leukemia


Azacitidine + MLN4924 + Venetoclax

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.